Hypertension is considered a major public health issue due to its high prevalence and
subsequent risk of cardiovascular and kidney diseases. Thus, the search for new …

Cardiovascular diseases (CVDs) are considered as a major cause of death worldwide.
Therefore, identifying and developing therapeutic strategies to treat and reduce the …

Venom and poison peptides are powerful biological weapons and have proven immense
pharmacological potential because of their high binding affinity to a wide range of molecular …

Toxicofera reptile venoms are composed of several toxins, including serine proteases.
These proteases are glycosylated enzymes that affect the prey's hemostatic system. Their …

Varespladib (VPL) was primarily developed to treat inflammatory disturbances associated
with high levels of serum phospholipase A2 (PLA2). VPL has also demonstrated to be a …

Abstract Background: Tityus serrulatus venom (Ts venom) is a complex mixture of several
compounds with biotechnological and therapeutical potentials, which highlights the …

Abstract Development of therapeutic agents that have fewer adverse effects and have higher
efficacy for diseases, such as cancer, metabolic disorders, neurological diseases, infections …

Ischemic heart disease (IHD), especially myocardial infarction (MI), is a leading cause of
death worldwide. Although coronary reperfusion is the most straightforward treatment for …

Snakes of the genus Lachesis, commonly known as bushmasters, are the largest venomous
snakes in the Americas. Because these snakes have their habitats in areas of remote forests …

Abstract Background: Lachesis muta rhombeata (Lmr) is the largest venomous snake in
Latin America and its venom contains mainly enzymatic components, such as serine and …